Common questions about Marevan (FAQ)
Q: What is the main reason doctors prescribe Marevan?
According to official product information, Marevan is prescribed for the prophylaxis (prevention) and treatment of conditions such as venous thrombosis (blood clots in the veins) and pulmonary embolism. It is also indicated to reduce the risk of thromboembolic complications associated with conditions like atrial fibrillation.
Q: Is Marevan a blood thinner?
Official documents describe the medication as an anticoagulant. This term refers to a medicine that is used to interfere with the body’s clotting process.
Q: What is INR, and how does it relate to taking Marevan?
The INR (International Normalized Ratio) is a standardized measure used to check how quickly a person's blood clots. Regulatory documents indicate that the INR is the essential tool healthcare providers use to ensure the dose of Marevan is adjusted correctly.
Q: How long does it usually take for Marevan to start working?
An initial effect can begin within 24 hours of taking the medicine. However, the full, stable anticoagulant effect often takes 3 to 4 days (72 to 96 hours) to develop. This delay is why dosing adjustments are guided by blood tests taken over several days.
Q: Is Marevan a long-term medicine?
Official guidelines indicate that for specific medical issues, such as having a mechanical heart valve or atrial fibrillation, the medicine may be recommended for long-term or indefinite use. The exact duration of therapy is based on a healthcare provider's clinical assessment.
Q: Are there common foods or drinks that interact with Marevan?
Regulatory labels caution that foods and drinks that contain Vitamin K can affect the effectiveness of Marevan and require careful monitoring. Furthermore, official patient information states that consumption of alcohol and cranberry juice should be limited.
Q: Does eating green vegetables affect Marevan?
Yes, patient information notes that green leafy vegetables are particularly rich in Vitamin K. Since Marevan works by counteracting Vitamin K, consuming large amounts of these foods may potentially impact INR levels.
Q: Can alcohol be consumed while taking Marevan?
Official patient information states that the consumption of alcohol should be limited or avoided. This is because alcohol consumption can significantly affect the stability of the INR, which may be associated with an increased risk of a bleeding event.
Q: What are the most commonly reported side effects of Marevan?
According to official regulatory documents, the most common adverse effect is an increased risk of bleeding. Other frequently reported, though often less serious, effects can include general symptoms like nausea, diarrhea, and hair loss.
Q: Is bruising or bleeding common when taking Marevan?
Bleeding is described in regulatory sources as the most common and most serious adverse effect. Minor bleeding, such as easy bruising or minor gum bleeding, is reported as common.
Q: Is it normal to feel more tired when starting Marevan?
Fatigue is listed as a possible side effect of the medicine. However, official warnings also note that feeling overly tired can sometimes be a sign of a more serious, though rare, condition like internal bleeding.
Q: What signs of bleeding should someone watch out for while on Marevan?
Official warnings describe serious bleeding signs which are associated with the need for immediate medical review. These include seeing blood in the urine or stool (which may appear black or tarry), vomiting blood, experiencing a severe headache, or having any prolonged bleeding that will not stop.
Q: Can Marevan be taken with common pain relievers like ibuprofen?
Regulatory documents advise caution or against combining Marevan with Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen. Official warnings state that using these pain relievers together significantly increases the risk of serious bleeding events.
Q: Are there any herbal supplements that should be avoided with Marevan?
Official patient information indicates that several herbal products may interact with Marevan, including St. John's wort, garlic, Ginkgo biloba, and ginseng. Official documentation notes that disclosure of all supplements to a healthcare provider is important.
Q: Can antibiotics interfere with Marevan?
Yes, regulatory documents caution that antimicrobial agents (including many antibiotics) are known to interact with Marevan. This type of interaction often requires a patient's INR to be monitored more closely and may require a temporary adjustment to the Marevan dose.
Q: What common medicines need to be reviewed by a doctor before starting Marevan?
Regulatory labels emphasize that careful review of all prescription and non-prescription medicines by a healthcare provider is important before starting treatment. Medicines that can significantly increase the risk of bleeding, such as NSAIDs, antiplatelet agents (like aspirin), and certain antibiotics, are particularly important to disclose.
Q: Is Marevan safe for use during pregnancy, according to official documents?
Use during pregnancy is generally contraindicated (not recommended) due to the risk of fetal harm and birth defects, according to regulatory warnings. However, an exception is noted in official documents for patients with specific mechanical heart valves when the benefit to the mother is considered to outweigh this risk.
Q: Can Marevan be used by children?
Yes, official guidelines describe specialized, weight-based dosing for use in the pediatric population. This indicates that the medicine's use is possible for children, but requires strict and specialized medical supervision.
Q: Is there an age limit for people who can take Marevan?
There is no absolute age limit specified in the product information. Official guidance highlights that older adults (typically 60 years and older) may show a greater sensitivity to the effects of the medicine and often require a lower starting and maintenance dose.
Q: What is the risk classification for Marevan during breastfeeding?
Regulatory documents note that warfarin, the active ingredient, is generally not found in human milk. For this reason, its use is considered acceptable, though close monitoring of both mother and baby for any signs of bleeding is advised.
Q: If I need surgery, do I need to stop taking Marevan?
Yes, if a patient is scheduled for elective surgery or any medical procedure, official guidelines state that a doctor or dentist may need to advise the patient to temporarily stop or change the dosage beforehand. This is a common practice to minimize bleeding risk during the procedure.
Q: Does Marevan affect dental procedures?
Regulatory patient information emphasizes that if a patient is planning any dental procedure, including surgery, it is important that the dentist or surgeon is informed that the patient is taking Marevan. This allows the care team to manage the bleeding risk appropriately.
Q: What research is available on the long-term use of Marevan?
Official regulatory labels include data from clinical trials that have examined the medicine’s use for long-term conditions like atrial fibrillation. These studies support the decision for long-term use when the risk and benefits are periodically reviewed by a healthcare provider.
Q: Is there evidence that Marevan reduces the risk of stroke?
Yes, the medicine is officially indicated to reduce the risk of thromboembolic events, which includes conditions such as stroke. Official documentation supports its use for this purpose in patients with certain risk factors, like atrial fibrillation.
Q: How often do people usually have their INR checked while taking Marevan?
Initially, INR is monitored daily until the blood test results stabilize within the target range. Once stable, official guidance indicates that periodic checks are performed, usually at intervals of 1 to 4 weeks, as determined by a healthcare professional.
Q: What should a patient know about vitamin K when taking Marevan?
Regulatory patient information strongly emphasizes that consistent consumption of Vitamin K is vital, as it directly affects how the medicine works in the body. Large, sudden changes in Vitamin K intake can destabilize the INR.
Q: Can Marevan interact with dietary supplements?
Yes, regulatory patient information advises patients to tell their doctor about all nutritional and dietary supplements they take. Certain supplements, such as Coenzyme Q10, have been noted in regulatory records as having the potential to interact.
Q: What are the general guidelines for patients starting Marevan?
Official patient counseling provides several key guidelines for starting treatment. These include the importance of frequent INR blood tests, reporting any signs of bleeding, informing all healthcare providers about the medicine, and maintaining consistent habits regarding diet and alcohol.
Q: Can I switch from another anticoagulant to Marevan?
Yes, official regulatory labels detail specific protocols for starting Marevan therapy in patients who are switching from other types of anticoagulants, such as heparin. This indicates that switching between these medicines is a standardized process managed by healthcare professionals.
Q: Do people on Marevan need to carry special identification?
While not explicitly mandated by all labels, regulatory patient counseling notes the importance of informing all healthcare providers (including dentists and surgeons) that the medicine is being taken. Carrying a medical identification card or bracelet is a common way to facilitate this essential safety information.
Q: What happens if someone accidentally takes too much Marevan?
Official warnings state that excessive anticoagulation, which can happen from taking too much medicine, can cause major or fatal bleeding. In this situation, contact with a healthcare professional or emergency services is needed immediately.
Q: What is the process for discontinuing Marevan if required?
Regulatory labels note that therapy should be reassessed periodically to determine its ongoing need. The process for discontinuing the medicine, if required, must be determined and managed only by a healthcare professional.
Q: What are the considerations for people with kidney problems taking Marevan?
Regulatory labels specifically address use in patients with renal dysfunction (kidney problems). These patients require caution and careful monitoring due to potential effects on how the body processes the medicine.
Q: What is the general duration of treatment with Marevan for atrial fibrillation?
Official guidelines indicate that for patients diagnosed with atrial fibrillation, treatment is often recommended to be indefinite (long-term). The specific duration of treatment is determined by the healthcare provider based on the patient's individual risk profile.
Q: What are the documented contraindications for using Marevan?
Contraindications are documented conditions where the risk of bleeding is greater than the benefit of treatment. These include having active ulceration or bleeding, recent or imminent surgery/procedures with a high bleeding risk, or having uncontrolled high blood pressure.
Q: Can Marevan be used by people with a history of bleeding ulcers?
Official regulatory documents list active gastrointestinal ulceration or bleeding as a contraindication. Furthermore, caution is advised against the use of the medicine in patients with a history of peptic ulcer disease or past gastrointestinal bleeding.
Q: What general expectations should patients have about taking Marevan?
Patient counseling information states expectations such as the need for frequent blood tests (INR) to guide dosing. Patients should also expect the possibility of an increased bleeding risk and must adhere strictly to the prescribed dose and schedule.
Q: How is the safety profile of Marevan generally described in official sources?
The safety profile, as described in official sources, is characterized by a narrow therapeutic range (the difference between an effective and a toxic dose). This requires close and regular blood monitoring (INR) due to the significant and documented risk of major or fatal bleeding.
Q: Can Marevan affect liver function?
Yes, regulatory labels mention that warfarin can cause liver problems and that patients with hepatic dysfunction should be carefully monitored. The liver plays a critical role in how the body metabolizes and clears the medicine.
Q: Is it possible to have an allergic reaction to Marevan?
Yes, regulatory information notes that patients should inform their doctor if they are allergic to warfarin or any of its ingredients. In rare cases, symptoms of a serious allergic reaction (hypersensitivity) may occur and require immediate attention.
